Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma

NCT00362570 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Oligoastrocytoma, Mixed
Anaplastic Oligodendroglioma

Interventions

DRUG: Temozolomide

Sponsor

Ohio State University Comprehensive Cancer Center